Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

Top 6 Stocks for November

By Sam Collins, InvestorPlace Chief Technical Analyst
Investors can use the high volatility to buy this month’s picks at reasonable prices. Here are six that stand out.

Top 5 Blue-Chip Stocks to Buy

By Louis Navellier, Editor, Growth Investor
There are two great sectors to play now -- and these are their finest blue-chip offerings. Pick up these shares before it's too late.

Shun Starbucks Stock and Stick With Dunkin’

By Peter Cohan, InvestorPlace Writer
Dunkin' Brands' valuation is low relative to its earnings growth, but Starbucks knocked it out of the park last quarter. See which is the better buy.

Ringing Up Brazil’s Biggest Telecom Player

By Will Ashworth, InvestorPlace Contributor
More than Siemens AG (SI), Tele Norte Leste Participacoes' (TNE) best days are ahead of it.

Sohu, Changyou — Value Plays on the Chinese Internet Market

By Peter Cohan, InvestorPlace Writer
Chinese Internet stocks Sohu and Changyou may be volatile, but their low PEG ratios are calling out to investors willing to take a risk with considerable upside.

3 Reasons Coinstar Is No Netflix

By Jamie Dlugosch, InvestorPlace Writer
Netflix and Coinstar (owner of Redbox) both rent movies -- but that's where the similarities end. Here's why Coinstar's sell-off is a buying opportunity.

Never Sell These 3 Stocks

By Lawrence Meyers, InvestorPlace Contributor
These three stocks epitomize reliability and make the short list of stocks you can -- and should -- buy and hold for a very long time. Forever, even.

Akamai Has Cooled, But Is Heating Up Once More

By Sam Collins, InvestorPlace Chief Technical Analyst
Akamai Technologies is down about 35% so far this year, but may be heating up again and could easily pop 10% to 15% in short order. Get the trade.

3 Stocks Under $12 Set to Double

By Lawrence Meyers, InvestorPlace Contributor
Whether they're undiscovered gems, damaged goods or in little-understood businesses, these under-$12 stocks have oodles of upside.

Altria Could Fire Up Your Portfolio

By Deborah OMalley, InvestorPlace Writer
This high-yielding stock could run significantly above its recent all-time high.

Buy Quest Software Shares; Pass on Oracle

By Peter Cohan, InvestorPlace Writer
While Oracle (ORCL) is a stronger company, its valuation is too high. Quest (QSFT) is attractively valued, especially if it can meet 2012 expectations.

Visa – Consumers Still Swiping, Stock Still Soaring

By Charles Sizemore, Chief Investment Strategist, The Freeport Society
Visa NYSE:V posted very strong earnings this week thanks to debit card and credit card growth, and hot emerging market revenue. Visa is a great stock to buy.

Take the Cure — Sell J&J, Buy GSK

By Will Ashworth, InvestorPlace Contributor
Johnson & Johnson and GlaxoSmithKline both have solid balance sheets, but GSK is poised to outperform its competitor.

Oversold ‘Fracking’ Supplier Has Breakout Potential

By Sam Collins, InvestorPlace Chief Technical Analyst
'Fracking' supplier Carbo Ceramics, Inc. is oversold. Here's how to profit.

Moody’s, McGraw-Hill Still Don’t Rate

By Peter Cohan, InvestorPlace Writer
If the Europe crisis really is resolved, both could enjoy a business rebound. However, Moody's (MCO) still would be an expensive way to buy that rebound.

5 Stocks to Play China’s Dominance

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader
Data shows China's economic growth could be increasing once again -- and these five stocks offer investors a way to profit from the country's prowess.

Why Nike Will Outrun Under Armour

By Will Ashworth, InvestorPlace Contributor
Nike and Under Armour are good performers, but in terms of stock price and infrastructure, Nike wins the race.

9 Recession-Proof Biotech Stocks To Cure What Ails You

By Louis Navellier, Editor, Growth Investor
Health care stocks stay firm during a down economy and investors should consider up-and-coming biotech stocks like Alexion, Alkermes, Biogen and Cepheid.

Should You Buy the Dow — Travelers

By Lawrence Meyers, InvestorPlace Contributor
Travelers Indemnity's solid underwriting and financials inspire confidence in its stock.
Load More Articles